References
- Rochat RW, Koonin LM, Atrash HK, et al. Maternal mortality in the United States: Report from the Maternal Mortality Collaborative. Obstet Gynecol 1988;72:91–7
- Lucas MJ, Leveno KJ, Cunningham FG. A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. N Engl J Med 1995;333:201–5
- The Eclampsia Trial Collaborative Group. Which anti-convulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet 1995345:1455–63
- Belfort MA, Saade GR, Moise KJ, et al. Nimodipine in the management of preeclampsia: maternal and fetal effects. Am J Obstet Gynecol 1994;171:417–24
- Coetzee EJ, Dommisse J, Anthony J. A randomised controlled trial of intravenous magnesium sulphate versus placebo in the management of women with severe pre-eclampsia. BrJ Obstet Gynaecol 1998;105:300–3
- Chua S, Redman CW. Are prophylactic anticonvulsants required in severe pre-eclampsia? Lancet 1991;337:2504
- Hall DR, Odendaal HJ, Smith M. Is the prophylactic adminis-tration of magnesium sulphate in women with pre-eclampsia indicated prior to labour? BrJ Obstet Gynaecol 2000;107:903–8
- Pritchard JA. The use of magnesium sulfate in preeclampsia—eclampsia. J Reprod Med 1979;23:107–14
- Zuspan FP. Treatment of severe preeclampsia and eclampsia. Clin Obstet Gynecol 1966;9:954–72
- Sibai BM. Magnesium sulfate is the ideal anticonvulsant in preeclampsia—eclampsia. Am J Obstet Gynecol 1990;162: 1141–5
- Witlin AG. Prevention and treatment of eclamptic convul-sions. Clin Obstet Gynecol 1999;42:507–18
- Ascarelli MH, Johnson V, May WL, et al. Individually deter-mined postpartum magnesium sulfate therapy with clinical parameters to safely and cost-effectively shorten treatment for pre-eclampsia. Am J Obstet Gynecol 1998;179:952–6
- American College of Obstetricians and Gynecologists. Hyper-tension in pregnancy. ACOG Technical Bulletin 1996;219:1–8
- Usta IM, Sibai BM. Emergent management of perpetual eclampsia. Obstet Gynecol Clin North Am 199522:315–35
- Miles JF, Martin JN Jr, Blake PG, et al. Postpartum eclampsia: a recurring perinatal dilemma. Obstet Gynecol 1990;76:328–31
- Lubarsky SL, Barton JR, Freidman SA, et al. Late postpartum eclampsia revisited. Obstet Gynecol 1994;83:502–5
- Morris MC, Twickler DM, Hatab MR, et al. Cerebral blood flow and cranial magnetic resonance imaging in eclampsia and severe preeclampsia. Obstet Gynecol 1997;89:561–8
- Williams KP, Galemeau F, Wilson S. Changes in cerebral perfusion pressure in puerperal women with preeclampsia. Obstet Gynecol 1998;92:101649
- Belfort MA, Saade GR, Grunewald C, et al. Association of cerebral perfusion pressure with headache in women with preeclampsia. Br J Obstet Gynaecol 1999;106:814–21
- Belfort MA, Saade GR, Yared M, et al. Change in estimated cerebral perfusion pressure after treatment with nimodip Me or magnesium sulfate in patients with preeclampsia. Am J Obstet Gynecol 1999;181:402–7
- Ferrazzani S, DeCarolis S, Pomini F, et al. The duration of hypertension in the puerperium of preeclamptic women: relationship with renal impairment and week of delivery. Am J Obstet Gynecol 1994;171:50642
- Makkonen N, Harju M, Kirk Men P. Postpartum recovery after severe pre-eclampsia and HELLP-syndrome. J Perinat Med 1996;24:641–9
- Rajkovic A, Mahomed K, Malinow MR, et al. Plasma homo-cyst(e)ine concentrations in eclamptic and preeclamptic African women postpartum. Obstet Gynecol 199994:355–60
- Hubel CA, McLaughlin MK, Evans RW, et al. Fasting serum triglycerides, free fatty acids, and malondialdehyde are increased in preeclampsia, are positively correlated, and decrease within 48 hours postpartum. Am J Obstet Gynecol 1996;174:975–82